Drug Type Small molecule drug |
Synonyms Darglitazone, Darglitazone sodium (USAN), 达格列酮 + [3] |
Target |
Mechanism PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H20N2O4S |
InChIKeyQQKNSPHAFATFNQ-UHFFFAOYSA-N |
CAS Registry141200-24-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 1 | US | - | |
Diabetes Mellitus, Type 2 | Phase 1 | - | - |